Study into conolidine has led to discovery of an opioid receptor in the body named ACKR3/CXCR7. ACKR3 appears to be probably the most desired target for conolidine, which also disregards the other 4 classical opioid receptors(three). There may be interest in working with conolidine to be a pain-reliever depending https://georgef319mno9.bloggazzo.com/profile